• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者的冠心病风险:一项荟萃分析。

Risk of Coronary Heart Disease in People with Chronic Obstructive Pulmonary Disease: A Meta-Analysis.

机构信息

Medical College, Soochow University, Suzhou, Jiangsu Province, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2021 Oct 27;16:2939-2944. doi: 10.2147/COPD.S331505. eCollection 2021.

DOI:10.2147/COPD.S331505
PMID:34737558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558317/
Abstract

BACKGROUND

Patients with chronic obstructive pulmonary disease complicated with coronary heart disease are a major public health problem, but it has not been widely accepted by the public or health professionals, the purpose of this study is to conduct a meta-analysis of the literature reports on the risk of coronary heart disease in patients with chronic obstructive pulmonary disease.

METHODS

Data sources are PubMed and Web of Science searched up to August 2021. Design is meta-analysis.

RESULTS

Literature searches yielded 8877 records, meta-analysis showed that the risk of coronary heart disease in chronic obstructive pulmonary disease patients was 1.24 times higher than that in non-chronic obstructive pulmonary disease patients (HR=1.24,95% CL 1.16-1.32).

CONCLUSION

The findings suggest that patients with chronic obstructive pulmonary disease are at a higher risk of developing coronary heart disease than non-chronic obstructive pulmonary disease patients.

摘要

背景

慢性阻塞性肺疾病合并冠心病患者是一个主要的公共卫生问题,但尚未被公众或卫生专业人员广泛接受,本研究旨在对文献报告中慢性阻塞性肺疾病患者患冠心病的风险进行荟萃分析。

方法

检索数据来源于 PubMed 和 Web of Science,截至 2021 年 8 月。设计为荟萃分析。

结果

文献检索得到 8877 条记录,荟萃分析显示慢性阻塞性肺疾病患者患冠心病的风险高于非慢性阻塞性肺疾病患者(HR=1.24,95%CL1.16-1.32)。

结论

研究结果表明,慢性阻塞性肺疾病患者发生冠心病的风险高于非慢性阻塞性肺疾病患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4042/8558317/0a3046c11e1a/COPD-16-2939-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4042/8558317/976f847b51d7/COPD-16-2939-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4042/8558317/0a3046c11e1a/COPD-16-2939-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4042/8558317/976f847b51d7/COPD-16-2939-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4042/8558317/0a3046c11e1a/COPD-16-2939-g0002.jpg

相似文献

1
Risk of Coronary Heart Disease in People with Chronic Obstructive Pulmonary Disease: A Meta-Analysis.慢性阻塞性肺疾病患者的冠心病风险:一项荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2021 Oct 27;16:2939-2944. doi: 10.2147/COPD.S331505. eCollection 2021.
2
Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review.慢性阻塞性肺疾病患者的跌倒发生率及相关因素:系统综述。
Respir Med. 2021 Jan;176:106284. doi: 10.1016/j.rmed.2020.106284. Epub 2020 Dec 10.
3
Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention.慢性阻塞性肺疾病对接受经皮冠状动脉介入治疗的冠心病患者生存的影响。
Am J Cardiol. 2004 Sep 1;94(5):649-51. doi: 10.1016/j.amjcard.2004.05.034.
4
[Peculiarities of primary health care organization for patients suffering from chronic obstructive pulmonary disease jointly with coronary heart disease].[慢性阻塞性肺疾病合并冠心病患者的基层医疗保健组织特点]
Wiad Lek. 2017;70(3 pt 1):466-469.
5
Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap.哮喘、COPD 和哮喘-COPD 重叠患者中的冠心病和心力衰竭。
BMJ Open Respir Res. 2020 Feb;7(1). doi: 10.1136/bmjresp-2019-000470.
6
Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.类风湿关节炎相关慢性阻塞性肺疾病:系统评价和荟萃分析。
Respir Res. 2019 Jul 9;20(1):144. doi: 10.1186/s12931-019-1123-x.
7
The relationship between chronic obstructive pulmonary disease and transcatheter aortic valve implantation--A systematic review and meta-analysis.慢性阻塞性肺疾病与经导管主动脉瓣植入术的关系——一项系统评价和荟萃分析。
Catheter Cardiovasc Interv. 2016 Mar;87 Suppl 1:570-8. doi: 10.1002/ccd.26443. Epub 2016 Feb 9.
8
Comorbidities of chronic obstructive pulmonary disease in Koreans: a population-based study.韩国慢性阻塞性肺疾病的合并症:一项基于人群的研究。
J Korean Med Sci. 2012 Aug;27(8):901-6. doi: 10.3346/jkms.2012.27.8.901. Epub 2012 Jul 25.
9
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies.慢性阻塞性肺疾病作为认知功能障碍的一个危险因素:当前研究的荟萃分析
J Alzheimers Dis. 2016 Feb 27;52(1):101-11. doi: 10.3233/JAD-150735.
10
[Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease].[慢性阻塞性肺疾病合并冠心病患者的心律失常]
Klin Med (Mosk). 2008;86(3):21-6.

引用本文的文献

1
Prevalence and predictors of coronary heart disease among individuals with and without obesity in North Dakota.北达科他州肥胖人群和非肥胖人群中心血管疾病的患病率及其预测因素。
PLoS One. 2024 Nov 8;19(11):e0313283. doi: 10.1371/journal.pone.0313283. eCollection 2024.
2
Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review.慢性阻塞性肺疾病患者的心血管风险:一项系统评价
J Clin Med. 2024 Aug 31;13(17):5173. doi: 10.3390/jcm13175173.
3
The Diagnosis and Treatment of COPD and Its Comorbidities.慢性阻塞性肺疾病及其合并症的诊断与治疗。

本文引用的文献

1
Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap.哮喘、COPD 和哮喘-COPD 重叠患者中的冠心病和心力衰竭。
BMJ Open Respir Res. 2020 Feb;7(1). doi: 10.1136/bmjresp-2019-000470.
2
Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者心血管合并症的管理
J Thorac Dis. 2020 May;12(5):2791-2802. doi: 10.21037/jtd.2020.03.60.
3
NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases.NLRP3炎性小体,心血管疾病发病机制和治疗中的一个免疫炎症靶点。
Dtsch Arztebl Int. 2023 Jun 23;120(25):434-444. doi: 10.3238/arztebl.m2023.027.
Clin Transl Med. 2020 Jan;10(1):91-106. doi: 10.1002/ctm2.13. Epub 2020 Apr 9.
4
Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease.慢性阻塞性肺疾病作为心血管疾病关键危险因素的研究进展。
Int J Chron Obstruct Pulmon Dis. 2020 Apr 14;15:755-764. doi: 10.2147/COPD.S238214. eCollection 2020.
5
Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重背景下心血管疾病危险因素对主要心血管事件预防和管理的影响
Front Cardiovasc Med. 2019 Jun 25;6:79. doi: 10.3389/fcvm.2019.00079. eCollection 2019.
6
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.慢性阻塞性肺疾病恶化和心脏事件。SUMMIT 随机临床试验的事后队列分析。
Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57. doi: 10.1164/rccm.201711-2239OC.
7
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].[2016年欧洲临床实践心血管疾病预防指南。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第六版(由10个学会的代表及特邀专家组成。在欧洲心血管预防与康复协会的特别贡献下制定)]
G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612. doi: 10.1714/2729.27821.
8
Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.气道阻塞与心肌梗死和冠心病死亡风险:一项具有 33 年随访期的全国健康检查调查。
Eur J Epidemiol. 2018 Jan;33(1):89-98. doi: 10.1007/s10654-017-0278-3. Epub 2017 Jul 7.
9
Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial.茚达特罗对肺萎陷的影响改善了过度充气的慢性阻塞性肺疾病患者的心功能:一项干预性、随机、双盲临床试验。
Int J Chron Obstruct Pulmon Dis. 2015 Sep 11;10:1917-23. doi: 10.2147/COPD.S91684. eCollection 2015.
10
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.合并症与慢性阻塞性肺疾病:患病率、对结局的影响及管理
Semin Respir Crit Care Med. 2015 Aug;36(4):575-91. doi: 10.1055/s-0035-1556063. Epub 2015 Aug 3.